Black Rock Inc. Stoke Therapeutics, Inc. Call Options Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STOK
# of Institutions
111Shares Held
50MCall Options Held
63KPut Options Held
111K-
Skorpios Trust14.4MShares$185 Million99.92% of portfolio
-
Redmile Group, LLC San Francisco, CA5.07MShares$65.1 Million2.7% of portfolio
-
Rtw Investments, LP New York, NY4.22MShares$54.2 Million0.92% of portfolio
-
Morgan Stanley New York, NY4.03MShares$51.6 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY3.37MShares$43.2 Million0.58% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $506M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...